ARBs may solve the global antibiotic crisis by 2020
A British biopharmaceuticals company, have developed Antibiotic Resistance Breakers which can restore the original potency against both Gram-positive and Gram-negative bacteria...
List view / Grid view
A British biopharmaceuticals company, have developed Antibiotic Resistance Breakers which can restore the original potency against both Gram-positive and Gram-negative bacteria...
A synthetic double-stranded RNA has potential for use as an anti-liver cancer vaccine...
New delivery system deletes disease-causing genes and reduces cholesterol...
Focused laser beam could help scientists map connections among neurons that underlie behaviour...
Researchers have engineered T-cells in the laboratory to combat tumours...
Changing the epigenetic code of a single gene is enough to cause a healthy breast cell to become abnormal...
A team of researchers have developed a new technology, which is promising to understand and treat ischemic diseases...
SMi are delighted to have, Nagy Habib, Head of HPB Surgery, Imperial College London and Co-Founder, MiNA Therapeutics, as the Keynote Address for day 1 at RNA Therapeutics 2018!
By stimulating a patient’s immune system, a drug already in use to treat a blood disorder can prevent the growth of a variety of solid tumours...
Scientists have identified a new treatment approach for patients with a rare inherited immune disorder...
Polymer nanoagents that can ‘light up’ tiny areas of diseased tissues that conventional methods fail to detect, have been created by a research team led by NTU Singapore.
Scientists have shown that it is possible to incorporate DNA analysis into antenatal screening for three serious chromosome disorders including Down's syndrome...
By surveying gene expression, researchers have created a reference atlas for understanding the biology of inflammatory bowel disease and food allergies, among other conditions...
Insights derived from FDG PET could improve treatment selection for patients with advanced non-small cell lung cancer...
Preclinical research suggests the potential utility of BPN14770, as a prospective treatment for Alzheimer's disease...